Status:
RECRUITING
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments
Lead Sponsor:
University of Chicago
Conditions:
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number o...
Eligibility Criteria
Inclusion
- Diagnosis of metastatic prostatic adenocarcinoma
- Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy
- Able to complete written surveys in English
Exclusion
- More than 2 prior systemic treatment regimens utilized in addition to castration.
Key Trial Info
Start Date :
December 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04705038
Start Date
December 18 2020
End Date
December 1 2025
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, United States, 60637